Danaher Corporation (DHR) : Mckinley Carter Wealth Services scooped up 974 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 24,482 shares of Danaher Corporation which is valued at $1,982,552.Danaher Corporation makes up approximately 1.01% of Mckinley Carter Wealth Services’s portfolio.
Other Hedge Funds, Including , Boston Advisors reduced its stake in DHR by selling 135,780 shares or 93.78% in the most recent quarter. The Hedge Fund company now holds 9,012 shares of DHR which is valued at $728,620. Danaher Corporation makes up approx 0.02% of Boston Advisors’s portfolio.Cornerstone Advisors reduced its stake in DHR by selling 9 shares or 3.88% in the most recent quarter. The Hedge Fund company now holds 223 shares of DHR which is valued at $18,030. Danaher Corporation makes up approx 0.02% of Cornerstone Advisors’s portfolio.Davenport Co reduced its stake in DHR by selling 3,321 shares or 0.4% in the most recent quarter. The Hedge Fund company now holds 837,167 shares of DHR which is valued at $67,844,014. Danaher Corporation makes up approx 1.01% of Davenport Co’s portfolio.
Danaher Corporation opened for trading at $81 and hit $81.34 on the upside on Thursday, eventually ending the session at $81.12, with a gain of 0.17% or 0.14 points. The heightened volatility saw the trading volume jump to 19,34,805 shares. Company has a market cap of $56,016 M.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.